Entity Addresses, Address Type [Axis] Business Contact [Member] Classes of share capital [axis] Ordinary Shares Par Value 0. 0001 Per Share [Member] Warrants To Purchase Ordinary Shares [Member] Components of equity [axis] Ordinary shares [member] Shares Application Money [member] Reserve of Change in Value of Merger Reserves [member] Reserve of gains and losses on financial assets measured at fair value through other comprehensive income [member] Reserve of change in value of foreign currency basis spreads [member] Retained earnings [member] Equity attributable to owners of parent [member] Non-controlling interests [member] Non-adjusting events after reporting period [axis] Announcing or commencing implementation of major restructuring [member] Classes of property, plant and equipment [axis] Fixtures and fittings [member] Range [axis] Bottom of range [member] Top of range [member] Office equipment [member] Medical Equipment [member] Computer equipment [member] Renovation [member] Laboratory [member] Aircraft [member] Mobile device [member] Laboratory Equipment [member] Machinery [member] Computer and ICT [member] Signboard [member] Motor vehicles [member] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Gross carrying amount [member] Accumulated Depreciation [Member] Classes of intangible assets other than goodwill [axis] Trademark [member] Patent [member] Technical Know How Of Stem Cells Cultivation [Member] Associates [axis] Alps Globemedics Sdn Bhd [member] Vax Biotech Sdn Bhd [member] Cilo Cybin Holdings Limited [member] Cilo Cybin Pharmaceutical [Member] Biological assets by type [axis] Chemical Reagents And Products [Member] Medical Substances And Chemical Stocks [member] Maturity [axis] Current [member] Not later than one month [member] Later than one month and not later than two months [member] Later than two months and not later than three months [member] Classes of financial liabilities [axis] Amount due to directors [member] Categories of related parties [axis] Total for all related parties [member] Counterparties [axis] Alps Life Science Inc [member] Not later than one year [member] Later than one year and not later than five years [member] Later than five years [member] Types of antidilutive instruments [axis] Public warrants [member] Private placement warrants [member] Levels of fair value hierarchy [axis] Level 3 of fair value hierarchy [member] Timing of transfer of goods or services [axis] Cellular therapy [member] Medical testing laboratory and aesthetics beauty services [member] Consultation fee [member] Sale of medicine and healthcare product [member] Goods or services transferred at point in time [member] Products and services [axis] External sales [member] Segments [axis] Medical and wellness segments [member] Life science segments [member] All other segments [member] Segment consolidation items [axis] Elimination of intersegment amounts [member] Operating segments [member] Inter segment sales [member] Trade receivables [member] Other receivables and deposits [member] Amount due from associates [member] Cash and bank balances [member] Trade payables [member] Other payables and accruals [member] Amount due to associates [member] Hire purchase liabilities [member] Lease liabilities [member] Later than two years and not later than five years [member] Undiscounted cash flow [member] Lease liability [member] Market Price Risk Sensitivity Analysis [Member] Subsidiaries [axis] Alps Life Sciences Inc [member] Alps global holding berhad [member] ALPS Biotech Sdn. Bhd. [member] Alpscap Berhad [member] ALPS Wellness Centre Sdn. Bhd. [member] Celestialab Sdn. Bhd. [member] Celebre Pro Medic Sdn. Bhd. [member] Mont Life (M) Sdn. Bhd. [member] Mygenome Sdn. Bhd. [member] TMC Global Holdings Sdn. Bhd. [member] Alps Insurance PCC INC [member] Dr Tham Seng Kong [Member] Chew Yoke Ling [Member] Chow Yoke Ling [member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Opinion [Text Block] Auditor Name Auditor Location Statement of financial position [abstract] ASSETS Non-Current Assets Property, plant and equipment Right-of-use assets Intangible assets Other investments Investment in associates Total Non-Current Assets Current Assets Inventories Trade receivables Other receivables, deposits and prepayments Amount due from associates Tax recoverable Cash and bank balances Total Current Assets Total Assets EQUITY AND LIABILITIES Share capital Merger reserves Accumulated losses Fair value reserve Foreign translation reserve Equity Attributable to the Owners of the Company Non-controlling interests Capital Deficiencies Non-Current Liabilities Amount due to directors Lease liabilities Deferred tax liabilities Warrant liability Total Non-Current Liabilities Current Liabilities Trade payables Other payables and accruals Amount due to associates Amount due to directors Lease liabilities Tax liabilities Total Current Liabilities Total Liabilities Total Equity and Liabilities Profit or loss [abstract] Revenue Cost of sales Gross profit Other operating income Finance income Distribution expenses Administrative expenses Other operating expenses Share result of associates Loss from operations Finance costs Loss before tax Income tax expense Loss for the financial year Other comprehensive (loss)/income, net of income tax Change in fair value of other investment Foreign currency translation Other comprehensive (loss)/income for the financial year Total comprehensive loss for the financial year Loss for the financial year attributable to: Owners of the Company Non-controlling interests Loss for the financial year Total comprehensive loss for the financial year attributable to: Owners of the Company Non-controlling interests Total comprehensive loss for the financial year Loss per share - basic Loss per share - diluted Statement of changes in equity [table] IfrsStatementLineItems [Line Items] Balance Contributions by and distribution to owners of the Company Issuance of shares pursuant to investment in combining entities Arising from part dilution of equity interest in a subsidiary Loss for the financial year Other comprehensive income (loss) Total comprehensive income/(loss) for the financial year Transaction with owners Adjustment on acquisition of subsidiaries Effect on merger acquisition Issuance of shares during the financial year Balance Statement of cash flows [abstract] CASH FLOWS USED IN OPERATING ACTIVITIES Loss before tax Changes in working capital: Amortisation of intangible assets Amortisation of right-of-use assets Depreciation of property, plant and equipment Finance income Gain on loan modification Gain on disposal of other investment Interest expenses Property, plant and equipment written off Bad debts written off Impairment loss on trade receivables Allowance for slow moving inventories Loss on disposal of investment in associates Fair value gain on warranty liability Reversal of impairment loss on investment in associate Share of results of associates Operating loss before changes in working capital Inventories Trade receivables Other receivables, deposits and prepayments Trade payables Other payables and accruals Cash Used In Operations Interest received Tax paid Tax refund Net Cash Used In Operating Activities CASH FLOWS USED IN INVESTING ACTIVITIES Acquisition of associates Advances to associates Purchase of property, plant and equipment Net Cash Used In Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from issuance of shares Advances from directors Interest paid Repayment of hire purchase liabilities Repayment of lease liabilities Advances from associates Net Cash From Financing Activities NET INCREASE IN CASH AND CASH EQUIVALENTS Effect of exchange differences CASH AND CASH EQUIVALENTS AT BEGINNING OF THE FINANCIAL YEAR CASH AND CASH EQUIVALENTS AT END OF THE FINANCIAL YEAR Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Type [Axis] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Trading Arrangements, by Individual [Table] Trading Arrangement [Axis] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Cybersecurity Risk Management, Strategy, and Governance [Abstract] Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity Risk Management Third Party Engaged [Flag] Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Cybersecurity Risk Board of Directors Oversight [Text Block] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Cybersecurity Risk Role of Management [Text Block] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Material Cybersecurity Incident [Abstract] Material Cybersecurity Incident Nature [Text Block] Material Cybersecurity Incident Scope [Text Block] Material Cybersecurity Incident Timing [Text Block] Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block] Material Cybersecurity Incident Information Not Available or Undetermined [Text Block] Corporate Information Corporate Information Basis Of Presentation Basis of Presentation Material Accounting Policy Information Material Accounting Policy Information Critical Accounting Judgements And Key Sources Of Estimation Uncertainty Critical accounting judgements and key sources of estimation uncertainty Disclosure of detailed information about property, plant and equipment [abstract] Property, plant and equipment Disclosure of quantitative information about leases for lessee [abstract] Right-of-use assets Disclosure of detailed information about intangible assets [abstract] Intangible assets Other Investments Other investments Investment In Associates Investment in associates Inventories Inventories Trade Receivables Trade receivables Other Receivables Deposits And Prepayments Other receivables, deposits and prepayments Disclosure of transactions between related parties [abstract] Related party transactions Disclosure of classes of share capital [abstract] Share capital Merger Reserves Merger reserves Fair Value Reserve Fair value reserve Foreign Translation Reserve Foreign translation reserve Lease liabilities [abstract] Lease liabilities Deferred Tax Liabilities Deferred tax liabilities Warrant Liability Warrant liability Trade Payables Trade payables Other Payables And Accruals Other payables and accruals Revenue Revenue Notes and other explanatory information [abstract] Other operating income Finance costs Loss Before Tax Loss before tax Income tax expense Loss Per Ordinary Share Loss per ordinary share Capital Commitment Capital commitment Disclosure of cash flow statement [text block] Reconciliation of liabilities arising from financing activities Disclosure of operating segments [abstract] Operating segments Disclosure of detailed information about financial instruments [abstract] Financial instrument Capital Management Capital management List Of Subsidiaries Are As Follows List of subsidiaries are as follows Significant Event And Subsequent Event Significant event and subsequent event Date Of Authorisation For Issue Date of authorisation for issue Basis of accounting Functional and presentation currency Basis of consolidation Non-controlling interests Investment in associates Warrant liability Revenue Property, plant and equipment Leases Inventories Financial instruments Impairment of financial assets Impairment of non-financial assets Segments reporting Intangible assets Schedule of property plant and equipment Schedule of detailed information about property plant and equipment Schedule of right of use assets Schedule of intangible assets Schedule of other investments Disclosure of associates [table] Schedule of investment in associates Schedule of details of associates Schedule of financial information represents the amount in the financial statements Schedule of financial information to the carrying amount of interest Schedule of inventories Schedule of trade receivables Schedule of movement in the allowance for impairment losses Schedule aged analysis of trade receivables Schedule of other receivables deposits and prepayments Schedule of consolidated financial statements the related party transactions Schedule of key management personnel Schedule of share capital Schedule of lease liabilities Schedule of maturity analysis Schedule of lease liabilities Schedule of deferred tax liabilities Schedule of warrant liability Schedule of fair value of the warrants Schedule of level 3 fair value inputs Schedule of other payables and accruals Schedule of revenue Schedule of other operating income Schedule of finance costs Schedule of loss before tax Schedule of income tax expense Schedule of reconciliation of income tax credit Schedule of estimated amount of temporary differences Schedule of unutilised tax losses Schedule of basis loss per ordinary share Schedule of capital commitment Schedule of reconciliation of liabilities arising from financing activities Schedule of operating segments Schedule of financial assets and liabilities Schedule of maturity profile of the group’s financial liabilities Schedule of list of subsidiaries Disclosure of non-adjusting events after reporting period [table] Shares issued Exchange ratio Net loss Working capital deficits Shareholders, equity working capital Disclosure of detailed information about property, plant and equipment [table] Depreciation rate, property, plant and equipment Closing foreign currency exchange rates Disclosure of reconciliation of changes in goodwill [table] As at March 31, 2025/April 1, 2025 Additions Exchange difference Reclassification As at March 31, 2026 Charge for the financial year Property,plant and equipment, carrying amount Right of use assets at cost Additions Derecognition arising from lease termination Exchange difference Right of use assets at cost Right of use assets accumulated amortization Charge for the financial year Derecognition arising from lease termination Exchange difference Right of use assets accumulated amortization As at March 31, 2025 Intangible assets accumulated depreciation Exchange difference Additions Intangible assets accumulated depreciation Charge for the financial year Intangible assets, carrying amount Gross profit margin Revenue growth rate percentage Discount rate percentage Schedule Of Other Investments As at April 1 Reclassification from Investment in Associates during the financial year (Note 9) Fair value through other comprehensive income Exchange Differences As at March 31 As at April 1 Disposal during the financial year Exchange Differences Unquoted shares at cost , net As at March 31 Schedule Of Investment In Associates Unquoted shares - at cost beginning Disposal during the financial year Reclassification to Other Investment during the financial year (Note 8) Unquoted shares- at cost end Accumulated impairment loss beginning Reversal of impairment during the financial year Exchange difference Accumulated impairment loss ending Unquoted shares- at cost, net Share of post-acquisition reserve beginning Share profit((loss) during the financial year Share of post-acquisition reserve ending Share of post- acquisition reserve, net Exchange differences Investment in associates Place of incorporation Effective equity interest Principal activities Non-current assets Current assets Total assets Current liabilities Total liabilities Net assets of the associate Revenue for the financial year (Loss)/Profit for the financial year Share of (loss)/profit of the associate Proportion of net assets of the associate Exchange differences Carrying amount of the Group’s interest in associate Total consideration Loss of disposal Disclosure of detailed information about biological assets [table] Inventories of Trading At cost Beauty and healthcare product Stem cells Stem cells Inventories Cost of inventories recognised as expense during period Allowance for slow moving inventories Schedule Of Trade Receivables Trade receivables Less: Allowance for expected credit losses Current trade receivables Schedule Of Movement In Allowance For Impairment Losses As at April 1 Impairment losses recognized Exchange difference As at March 31 Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table] Trade receiavble gross Trade receiavble specific allowance Trade receiavble net Trade receiavble gross Trade receiavble specific allowance Trade receiavble net Individual impaired gross Trade receiavble specific allowance Individual impaired Individual impaired net Trade receiavble gross Trade receiavble specific allowance Schedule Of Other Receivables Deposits And Prepayments Other receivables Deposits Prepayments Other receivables deposits and prepayments Agent commission Management fee income Agent commission Patent License Agreement Fee Salaries and other emoluments Defined contribution plans Total Disclosure of financial liabilities [table] Related party term Interest bearing, interest rate Number of shares issued and fully paid Issued capital Issue of ordinary share number of shares Issuance of shares during the financial year Adjustment on acquisitions of subsidiaries shares Adjustment on acquisition of subsidiaries value Issue of shares to investments of combining entities shares Issuance of shares pursuant to investment of combining entities value Number of shares issued and fully paid Issued capital Disclosure of offsetting of financial assets [table] Issue of ordinary shares Converted into aggregate of new ordinary shares Issue of ordinary shares Issuance of shares during the financial year Adjustment on acquisition of subsidiaries shares Adjustment on acquisition of subsidiaries value Issuance of shares pursuant to investment of combining entities value As at April 1 Additions Accretion of interest Payments As at March 31 Total minimum lease payments Less: Unearned interest Present value of lease liabilities Current Non-current Incremental borrowing rate Total cash outflows for lease Schedule Of Deferred Tax Liabilities As at April 1 Property, plant and equipment Exchange differences As at March 31 Schedule Of Warrant Liability As at 1 April Effect on merger acquisition Change in fair value As at 31 March Schedule Of Fair Value Of Warrants Fair value of Public Warrants per share Fair value of Private Placement Warrants per share Disclosure of fair value measurement of assets [table] Volatility Volatility Volatility Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table] Warrants issued Exercise price warrants Warrant liability Schedule Of Other Payables And Accruals Other payables Accruals Deposit received Other payables and accruals Disclosure of disaggregation of revenue from contracts with customers [table] Revenue from contracts with customers: Revenue from contracts with customer Timing of revenue recognition: At a point in time Other income Sundry income Fair value gain on warrant liability Gain on foreign exchange Gain on loan modification Other operating income Hire purchase liabilities Lease liabilities Finance costs Schedule Of Loss Before Tax Current financial year Under provision in previous year Amortisation of intangible assets Expenses relating to short-term leases Impairment loss on trade receivable Reversal of impairment loss on associate Loss on disposal of associate Salaries, wages and allowances Employees Provident Fund Other employees’ benefit Loss before tax Staff costs Current financial year Over provision for prior years  Tax payable for the current year Current financial year Under provision in prior years Income tax credit/(expense) Loss before tax Taxation at statutory rate of 24% (2025: 24%; 2024: 24%) Taxation at statutory rate, percent Non-taxable income Expenses not deductible Deferred tax not recognized Over provision of current tax in prior years Under provision of deferred tax in prior years Temporary differences 2028 2029 2030 2031 2032 2033 2034 2035 2036 Unutilised tax losses Schedule Of Basis Loss Per Ordinary Share Loss attributable to owners of the Company (USD) Weighted average number of ordinary shares (units) Basic loss per ordinary share Diluted loss per ordinary share Exchange rate Schedule Of Capital Commitment - Purchase of property, plant and equipment Amount due to directors, Beginning Balance Amount due to directors, Cash flow Amount due to directors, Non-cash flow Changes Amount due to directors, Ending Balance Lease liabilities cash flows Lease liabilities non cash flows Amount due to associates, Beginning Balance Amount due to associates cash flow Amount due to associates non cash flow Amount due to associates, Ending Balance Liabilities arising from financing activities Beginning Balance Liabilities arising from financing activities cash flow Liabilities arising from financing activities non cash flow Liabilities arising from financing activities End Balance Total revenue Profit/(Loss) from operations Profit/(Loss) before tax Segment assets Segment liabilities Amortisation of intangible assets Additional of property, plant and equipment Finance costs Share of results in associates Other material non cash items Segment liabilities Depreciation of property, plant and equipment Financial assets at amortised cost Financial assets Other investment Financial liabilities at amortised cost Financial liabilities Trade and other current payables Non-interest bearing, other payables and accruals Non-interest bearing, amount due to directors Non-interest bearing, amount due to directors Interest bearing, lease liabilities Non-interest bearing and interest bearing Disclosure of subsidiaries [table] Name of company Place of incorporation Effective interest rate Place of incorporation Date of acquisition Ownership percentage of equity Borrowing cost converted to equity Other investments non current. Other receivables deposits and prepayments. Tax recoverable. Cash and bank balances. Share application money. Merger reserves. Fair value reserve. Foreign translation reserve. Amount due to directors non current. Amount due to associates. Amount due to directors. Hire purchase liabilities current. Other operating incomes. Other operating expenses. Share result of associates. Unrealised loss from change in fair value of other investment. Profit loss attributable. Comprehensive income loss attributable to non controlling interest. Shares Application Money [member] Reserve of Change in Value of Merger Reserves [member] Contributions by and distribution to owners of company. Arising from part dilution of equity interest in subsidiary company. Transaction with owners. Loss before tax. Amortisation of right of use assets. Property plant and equipment written off. Tax paid. Income taxes refund. Acquisition of associates. Advances to associates. Advances from directors. Proceeds from lease liabilities. Advances from associates. Effect of exchange rate excluding increase decrease in changes on cash and cash equivalents. Disclosure of corporate information explanatory. Working capital deficits. Description of accounting policy for non controlling interests explanatory. Medical Equipment [member] Renovation [member] Laboratory [member] Mobile device [member] Laboratory Equipment [member] Computer and ICT [member] Signboard [member] Accumulated Depreciation [Member] Exchange difference. Right of use assets accumulated amortization. Right of use assets accumulated amortization change in financial year. Right of use assets disposals of accumulated amortization. Acquisitions through business combinations right of use assets accumulated amortisation. Trademark [member] Patent [member] Technical know how of stem cells cultivation [member] Good will exchange difference. Other Investment Net. Disclosure of investment in associates explanatory. Disclosure of investments in associates explanatory. Unquoted shares at cost gross. Accumulated impairment loss. Unquoted shares at cost net. Share of post acquisition reserve gross. Share of loss profit during financial year. Share of post acquisition reserve net. Exchange differences. Investment in associates. Vax Biotech Sdn Bhd [member] Alps Globemedics Sdn Bhd [member] Cilo Cybin Holdings Limited [member] Share of loss profit of associate. Disclosure of detailed information about financial information to carrying amount of interest explanatory. Proportion of net assets of associate. Carrying amount of groups interest in associate. Disclosure of detailed information about inventories explanatory. Inventories consumable. Chemical Reagents And Products [Member] Medical Substances And Chemical Stocks [member] Disclosure of detailed information about trade receivables explanatory. Other receivables deposits and prepayment. Management fee income. Patent license agreement. Key management personnel compensation fee. Disclosure Of Merger Reserves Explanatory Allotment equity shares. Alps Life Science Inc [member] Disclosure Of Foreign Translation Reserve [Explanatory] Disclosure Of Fair Value Reserve [Explanatory] Disclosure Of Hire Purchase Liabilities Explanatory Issue of ordinary value subdivision. Issue of shares to investments of combining entities value. Disclosure of detailed information about share capital explanatory. Disclosure of detailed information about hire purchase liabilities explanatory. Hire purchase liabilities total outstanding. Interest in suspense. Hire purchase liabilitie principal outstanding. Hire purchase liabilities due current. Interest rate of hire purchase obligation percentage. Disclosure of loss before tax explanatory. Unearned lease interest. Disclosure of lease liabilities explanatory. Auditors remuneration underprovision. Incremental borrowing rate. Expenses Relating To Short Term Leases. Deferred tax liabilities property and equipment. Loss before taxes. Disclosure of detailed information about components of income tax expense benefit explanatory. Disclosure of other payables and accruals explanatory. Hire purchase liabilities non current. Disclosure Of Detailed Information About Reconciliation Of Income Tax Credit Explanatory. Disclosure of unutilised tax losses on expiration explanatory. Unutilised tax losses on expiration next twelve months. Unutilised tax losses on expiration year two. Unutilised tax losses on expiration year three. Unutilised tax losses on expiration year four. Unutilised tax losses on expiration year five. Unutilised tax losses on expiration year six. Unutilised tax losses on expiration year seven. Unutilised tax losses on expiration year eight. Unutilised tax losses on expiration year nine. Unutilised tax losses. Life science segments [member] Medical and wellness segments [member] External sales [member] Inter segment sales [member] Amortisation of intangible assets. Adjustment on acquisition of subsidiaries values. Disclosure Of Detailed Information About Financial Instrument Explanatory. Disclosure Of Share Application Monies Explanatory Interest bearing interest rate. Trade payables [member] Undiscounted cash flow [member] Other payables and accruals [member] Other payables and accruals. Amount due to associates [member] Amount due to directors [member] Lease liability [member] Hire purchase liabilities [member] Hire purchase liabilities. Disclosure of capital management explanatory. Disclosure of list of subsidiaries explanatory. Alps global holding berhad [member] Date of acquisition of subsidiary. ALPS Biotech Sdn. Bhd. [member] Alpscap Berhad [member] ALPS Wellness Centre Sdn. Bhd. [member] Celestialab Sdn. Bhd. [member] Celebre Pro Medic Sdn. Bhd. [member] Mont Life (M) Sdn. Bhd. [member] Mygenome Sdn. Bhd. [member] Quoted shares other investment net comprehensive income. Unquoted shares other investment net profit or loss. TMC Global Holdings Sdn. Bhd. [member] Alps Insurance PCC INC [member] Reclassification from investment in associates. Disclosure of date of authorisation for issue explanatory. Disposal during the financial year unquoted shares at cost. Reclassification to other investments unquoted shares at cost. Dr Tham Seng Kong [Member] Chew Yoke Ling [Member] Chow Yoke Ling [member] Nonadjusting events after reporting period [member] Unrealised loss from changes in fair value of other investments. Exhange differences on other comprehensive income. Exhange differences on profit or loss. Disposals during financial year. Issue of ordinary share number of shares. Issue of ordinary shares subdivisions. Adjustment on acquisitions of subsidiaries shares. Issue of shares to investments of combining entities shares. Adjustment on acquisitions of subsidiaries values. Issue of shares to investments of combining entities values. Adjustments on acquisition of subsidiaries shares. Issue of ordinary share. Issue of share to investments of combining entities value. Convertible Promissory Note [member] Percentage of discount on issue. Number of ordinary class a shares issued and fully paid. Exercise price per share. Debt repayment terms. Disclosure Of Trade Receivables Explanatory Disclosure Of Detailed Information About Deferred Tax Liabilities Explanatory Disclosure Of List Of Subsidiaries Note Explanatory Disclosure Of Detailed Information About Of Right Of Use Assets Explanatory Disclosure Of Significant Event Period Explanatory Schedule Of Estimated Useful Lives Of Property Plant And Equipment Explanatory Cellular therapy [member] Medical testing laboratory and aesthetics beauty services [member] Consultation fee [member] Sale of medicine and healthcare product [member] Other receivables and deposits [member] Amount due from associates [member] Cash and bank balances [member] Adjustment on acquisition of subsidiaries. Effect on merger acquisition Disclosure of lease liabilities recognized and movements explanatory. Additions on lease liabilities. Change in fair value of warrant liability amount. Merger acquisition warrant liability amount. Disclosure of detailed information about warrant liability explanatory Public warrants [member] Private placement warrants [member] Uniform operating income. Deferred tax expense income not recognized. Disclosure of capital commitment explanatory Disclosure of capital expenditure explanatory. Disclosure of loss before taxes explanatory Alps Life Sciences Inc [member] Accretion of interest on lease liabilities. Disclosure of information details about reconciliation of liabilities arising from financing activities explanatory. Amount due to directors of cash flow. Amount due to directors of non cash flow. Proceeds from lease liabilities non cash flow Advances due to associates non cash flow. Liabilities arising from financing activities cash flow. Liabilities arising from financing activities non cash flow. Amount due to associates current liabilities. Amount due to directors current liabilities. Issue of ordinary share number of share. Issuance of shares during the financial year. Interest received. Allowance for slow moving inventories. Disclosure of lease liabilities component explanatory. Market price risk sensitivity analysis. Working capital. Equity attributable to owners of parent Equity Non-current liabilities AmountDueToDirectorsCurrentLiabilities Current liabilities Liabilities Equity and liabilities Cost of sales Gross profit Distribution and administrative expense General and administrative expense ShareResultOfAssociates Finance costs [Default Label] Tax expense (income) Profit (loss), attributable to non-controlling interests Profit loss attributable Comprehensive income, attributable to owners of parent Comprehensive income, attributable to non-controlling interests Comprehensive income loss attributable to non controlling interest GainOnWarrantyLiability Reversal of impairment loss Adjustments to reconcile profit (loss) Adjustments for decrease (increase) in inventories Adjustments for decrease (increase) in trade accounts receivable Adjustments for decrease (increase) in other current assets Adjustments for increase (decrease) in trade accounts payable Adjustments for increase (decrease) in trade and other payables Cash flows from (used in) operations InterestReceived TaxPaid Cash flows from (used in) operating activities AcquisitionOfAssociates Cash flows from (used in) investing activities Interest paid, classified as financing activities Payments of other equity instruments ProceedsFromLeaseLiabilities Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents before effect of exchange rate changes Cash and cash equivalents Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name DisclosureOfCorporateInformationExplanatory Disclosure of material accounting policy information [text block] Disclosure of property, plant and equipment [text block] Disclosure of quantitative information about right-of-use assets [text block] Disclosure of intangible assets [text block] Disclosure of investments other than investments accounted for using equity method [text block] DisclosureOfInvestmentInAssociatesExplanatory Disclosure of inventories [text block] Disclosure of trade and other receivables [text block] Disclosure of prepayments and other assets [text block] Disclosure of classes of share capital [text block] Disclosure of Merger Reserves Explanatory DisclosureOfFairValueReserveExplanatory DisclosureOfForeignTranslationReserveExplanatory DisclosureOfLeaseLiabilitiesExplanatory Disclosure of deferred taxes [text block] DisclosureOfWarrantLiabilityExplanatory Disclosure of trade and other payables [text block] Disclosure of other liabilities [text block] Disclosure of revenue [text block] Disclosure of other operating income (expense) [text block] DisclosureOfLossBeforeTaxExplanatory DescriptionOfAccountingPolicyForNonControllingInterestsExplanatory Description of accounting policy for investment in associates [text block] DescriptionOfAccountingPolicyForWarrantLiabilityExplanatory Description of accounting policy for recognition of revenue [text block] Description of accounting policy for property, plant and equipment [text block] Description of accounting policy for measuring inventories [text block] Description of accounting policy for intangible assets other than goodwill [text block] DisclosureOfLeaseLiabilitiesComponentExplanatory Increase (decrease) through net exchange differences, property, plant and equipment Right-of-use assets, revalued assets, at cost Additions to right-of-use assets Disposals, right-of-use assets RightofuseAssetsAccumulatedAmortization RightofuseAssetsAccumulatedAmortizationChangeInFinancialYear AcquisitionsThroughBusinessCombinationsRightofuseAssetsAccumulatedAmortisation AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwillExchangeDifference Additions other than through business combinations, intangible assets other than goodwill Amortisation, intangible assets other than goodwill QuotedSharesOtherInvestmentNetComprehensiveIncome UnquotedSharesOtherInvestmentNetProfitOrLoss ExhangeDifferencesOnProfitOrLoss OtherInvestmentNet UnquotedSharesAtCostGross DisposalDuringTheFinancialYearUnquotedSharesAtCost AccumulatedImpairmentLoss ExchangeDifference UnquotedSharesAtCostNet ShareOfPostAcquisitionReserveGross ShareOfPostAcquisitionReserveNet InvestmentInAssociates Current finished goods Inventories [Default Label] Allowance for slow moving inventories [Default Label] Current receivables from taxes other than income tax Other current receivables OtherExchangeDifferences CurrentTradeReceivableAllowance TradeReceivableNet CurrentTradeReceivableAllowanceIndividualImpaired AgentCommission Key management personnel compensation Number of shares issued and fully paid Share issue related cost Adjustment on acquisitions of subsidiaries shares IssueOfOrdinaryShare IssueOfOrdinaryShareNumberOfShare IssueOfShareToInvestmentsOfCombiningEntitiesValue Additions on lease liabilities Payments of lease liabilities, classified as financing activities UnearnedLeaseInterest Deferred tax liabilities [Default Label] DeferredTaxLiabilitiesPropertyAndEquipment Gains (losses) on exchange differences on translation of foreign operations, net of tax Warrant liability [Default Label] MergerAcquisitionWarrantLiabilityAmount Expected dividend as percentage, share options granted Risk free interest rate, share options granted Other operating income (expense) Interest expense on lease liabilities LossBeforeTaxes Current tax expense (income) Deferred tax expense (income) UnutilisedTaxLossesOnExpiration AmountDueToDirectors ProceedsFromLeaseLiabilitiesNonCashFlow Liabilities arising from financing activities AmortisationOfIntangibleAssets Country of incorporation of subsidiary